<DOC>
	<DOC>NCT02316431</DOC>
	<brief_summary>Diagnostic accuracy of PET/magnetic resonance and PET/CT will be compared concerning primary tumor, regional nodes, metastasis (TNM) staging and therapeutic influence. Workflow scenarios will be evaluated to create imaging protocols which are time efficient and diagnostically accurate.</brief_summary>
	<brief_title>Diagnostic Comparison of PET-magnetic Resonance and PET-CT in Patients With Oncologic Diseases</brief_title>
	<detailed_description />
	<criteria>Male and female patients from 1890 years Written informed consent Patients with a proven or suspected oncological disease referred for a clinically Indicated PET/CT with of without contrast media Pregnant or breast feeding women Non compliance of the patient to follow the study instructions (e.g. hearing problems, dementia) Inclusion in another clinical trial 30 days prior to inclusion Age &lt; 30years Contraindication for MRI (cardiac pacemaker, certain metal implants, claustrophobia Known allergies to contrast CT or MRI contrast media Patients with an glomerular filtration rate of &lt; 60ml/min/1.73m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>